The Budget - what does it mean for life sciences?
The 2025 Budget came at a crucial time for the UK’s innovative life sciences and biotech sector, which found itself at the mercy of global geopolitical forces and a prolonged funding drought. This Budget had the potential to deliver much-needed relief or further bad news, as the Chancellor faced a precarious financial landscape.
Despite the government’s welcome identification of life sciences as a priority growth sector, and the launch of the Sector Plan, there were still many rumoured policies that could have impacted the sector, including adjustments to business rates for R&D facilities and increases to taxes such as Capital Gains, alongside potential updates on Mansion House and the work of public institutions such as the British Business Bank and National Wealth Fund.
Hear from the BIA team as they break down the key announcements, their impact on the sector, and how they align with the government’s Life Sciences Sector Plan and wider industrial strategy.
